Definitive Healthcare Corp. (DH) stock plummeted by 9.6% in Monday's intraday trading session, following a price target cut by analysts at Deutsche Bank.
According to a research note from Deutsche Bank, the bank lowered its price target on Definitive Healthcare shares from $5 to $4, while maintaining a "Hold" rating on the stock.
The price target reduction reflects analysts' concerns about the company's prospects and future performance, which contributed to the sharp sell-off in Definitive Healthcare's stock price on Monday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.